SCHEMBL29965835

SCHEMBL29965835

Nc1cccc2[nH]c(-c3ccccc3)c(N)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.44
ESR2 Q92731 3/20 0.44
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 3/20 0.42
GAA P10253 2/20 0.42
HPGD P15428 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PARP1 P09874 3/20 0.40
CYP19A1 P11511 1/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
PTGS2 P35354 1/20 0.36
PLA2G10 O15496 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2224694 1.00 ESR1 (0.44) ESR1ESR2ALDH1A1KDM4EHSD17B10
Hydrochloric Acid SCHEMBL4557118 0.98 ESR1 (0.43) ESR1ESR2ALDH1A1KDM4EHSD17B10
Hydrochloric Acid SCHEMBL14576584 0.98 ESR1 (0.43) ESR1ESR2ALDH1A1KDM4EHSD17B10
SCHEMBL11797881 0.78 PLA2G2A (0.43) ESR1ESR2ALDH1A1KDM4EPARP1
SCHEMBL983399 0.76 ESR1 (0.61) ESR1ESR2ALDH1A1KDM4EHSD17B10
SCHEMBL14576583 0.75 MAP2 (0.40) ESR1ESR2ALDH1A1KDM4EHSD17B10
SCHEMBL11790809 0.75 ALDH1A1 (0.44) ALDH1A1KDM4ESMN1; SMN2PARP1MAPT
SCHEMBL4953231 0.74 ALDH1A1 (0.42) ESR1ESR2ALDH1A1KDM4EHSD17B10
SCHEMBL31550430 0.74 PSMB8 (0.38) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL3873727 0.73 PSMB8 (0.43) ALDH1A1KDM4EHSD17B10GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11484571-B2 Pharmaceutical compositions containing beta-2 microglobulin and methods of treating autoimmune diseases BETA INNOV (FR) 2022-11-01 US disclosed